Peter Ordentlich Syndax Pharmaceuticals Inc (SNDX) insider trading activity

Peter Ordentlich is Chief Scientific Officer of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 0 shares of SNDX, which is worth approximately $0. The most recent transaction as insider was on Feb 15, 2023, when has been sold 25,000 shares (Common Stock) at a price of $25.84 per share, resulting in proceeds of $646,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Peter Ordentlich Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 15 2023	SELL Open market or private sale	$646,000 $25.84 p/Share	25,000 Reduced 100.0%	0 Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	$169,750 $6.79 p/Share	25,000 Added 58.92%	17,428 Common Stock
Feb 01 2023	SELL Open market or private sale	$1,961 $28.43 p/Share	69 Reduced 100.0%	0 Common Stock
Jan 31 2023	BUY Other acquisition or disposition	$1,195 $17.32 p/Share	69 Added 50.0%	69 Common Stock
Dec 02 2022	SELL Open market or private sale	$430,860 $25.05 p/Share	17,200 Reduced 98.48%	265 Common Stock
Dec 02 2022	BUY Exercise of conversion of derivative security	$109,736 $6.38 p/Share	17,200 Added 49.62%	17,465 Common Stock
Dec 01 2022	SELL Open market or private sale	$195,078 $25.01 p/Share	7,800 Reduced 96.71%	265 Common Stock
Dec 01 2022	BUY Exercise of conversion of derivative security	$49,686 $6.37 p/Share	7,800 Added 64.5%	4,293 Common Stock
Aug 24 2022	SELL Open market or private sale	$626,000 $25.04 p/Share	25,000 Reduced 98.95%	265 Common Stock
Aug 24 2022	BUY Exercise of conversion of derivative security	$158,500 $6.34 p/Share	25,000 Added 91.18%	2,419 Common Stock
Jul 29 2022	BUY Other acquisition or disposition	$3,742 $14.12 p/Share	265 Added 50.0%	265 Common Stock
Feb 01 2022	SELL Open market or private sale	$23,510 $16.65 p/Share	1,412 Reduced 100.0%	0 Common Stock
Jan 31 2022	BUY Other acquisition or disposition	$17,495 $12.39 p/Share	1,412 Added 50.0%	1,412 Common Stock
Nov 23 2020	SELL Open market or private sale	$697,448 $23.27 p/Share	29,972 Reduced 100.0%	0 Common Stock
Nov 23 2020	BUY Exercise of conversion of derivative security	$92,314 $3.08 p/Share	29,972 Added 50.0%	29,972 Common Stock

Peter Ordentlich

Chief Scientific Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNDX shares.

Notify only if

Value

Insider Trading

Get notified when an Syndax Pharmaceuticals Inc insider buys or sells SNDX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Syndax Pharmaceuticals Inc

Track Activities on SNDX

Account